AR059972A1 - Administracion intranasal o inhalacional de virosomas - Google Patents
Administracion intranasal o inhalacional de virosomasInfo
- Publication number
- AR059972A1 AR059972A1 ARP070101114A ARP070101114A AR059972A1 AR 059972 A1 AR059972 A1 AR 059972A1 AR P070101114 A ARP070101114 A AR P070101114A AR P070101114 A ARP070101114 A AR P070101114A AR 059972 A1 AR059972 A1 AR 059972A1
- Authority
- AR
- Argentina
- Prior art keywords
- intranasal
- influenza
- composition
- inhalational administration
- virosomes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Composicion de virosomas de influenza que comprenden envolturas reconstituidas de dicho virus, donde las envolturas virales están totalmente derivadas de partículas virales de influenza, donde no se agrega lípido de una fuente externa a los virosomas reconstituidos, donde los virosomas comprenden los antígenos de influenza hemoaglutinina y/o neuroaminidasa o derivados de los mismos, donde no se agrega adyuvante y/o estimulante inmune a la composicion y donde la composicion es para administracion intranasal o inhalacional, composicion que está caracterizada porque una sola administracion intranasal o inhalacional a un ser humano es suficiente para la induccion de una respuesta inmune sistémica y/o una respuesta inmune local y/o una respuesta de linfocitos citotoxicos contra dichos antígenos de influenza, respuesta sistémica que está en concordancia con los criterios CHMP (Comité para productos medicinales ara uso humano) para una vacuna de influenza y donde la dosis de hemoaglutinina por cepa viral por administracion intranasal o inhalacional es menor de o igual a 30 ?g. La invencion también provee el uso de virosomas de influenza reconstituidos para la fabricacion de dicha composicion y formulaciones de vacuna preparadas para dicho uso. Dispositivo para administracion intranasal o inhalacional.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78446206P | 2006-03-22 | 2006-03-22 | |
EP06111534 | 2006-03-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR059972A1 true AR059972A1 (es) | 2008-05-14 |
Family
ID=38038698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070101114A AR059972A1 (es) | 2006-03-22 | 2007-03-20 | Administracion intranasal o inhalacional de virosomas |
Country Status (21)
Country | Link |
---|---|
EP (2) | EP2158921B1 (es) |
JP (1) | JP5285595B2 (es) |
KR (1) | KR20090016659A (es) |
AR (1) | AR059972A1 (es) |
AT (2) | ATE451931T1 (es) |
AU (1) | AU2007228736B2 (es) |
BR (1) | BRPI0709864A2 (es) |
CA (1) | CA2646895A1 (es) |
DE (1) | DE602007003815D1 (es) |
DK (2) | DK2158921T3 (es) |
EA (1) | EA014532B1 (es) |
ES (2) | ES2338382T3 (es) |
HR (2) | HRP20100144T1 (es) |
IL (1) | IL193840A (es) |
MY (1) | MY142996A (es) |
NO (1) | NO20084452L (es) |
PL (2) | PL2158921T3 (es) |
PT (2) | PT1996229E (es) |
SA (1) | SA07280116B1 (es) |
SI (2) | SI2158921T1 (es) |
WO (1) | WO2007107585A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2318044B1 (en) * | 2008-08-01 | 2015-12-02 | Gamma Vaccines Pty Limited | Influenza vaccines |
CA2826234A1 (en) * | 2010-11-02 | 2012-05-10 | Hector Manuel Zepeda Lopez | Novel vaccines against the a/h1n1 pandemic flu virus |
US11523988B2 (en) | 2018-11-29 | 2022-12-13 | Catalent U.K. Swindon Zydis Limited | Oral dispersible vaccine comprising virosomes |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9018690D0 (en) * | 1990-08-24 | 1990-10-10 | Wellcome Found | Vaccines |
EP1447080A1 (en) * | 2003-02-13 | 2004-08-18 | Bestewil Holding B.V. | Method for producing virosome-like particles |
TWI329130B (en) * | 2003-06-19 | 2010-08-21 | Bestewil Holding Bv | Functionally reconstituted viral membranes containing adjuvant |
-
2007
- 2007-03-20 AR ARP070101114A patent/AR059972A1/es not_active Application Discontinuation
- 2007-03-21 SI SI200730842T patent/SI2158921T1/sl unknown
- 2007-03-21 ES ES07727166T patent/ES2338382T3/es active Active
- 2007-03-21 DK DK09178084.1T patent/DK2158921T3/da active
- 2007-03-21 AT AT07727166T patent/ATE451931T1/de active
- 2007-03-21 ES ES09178084T patent/ES2375436T3/es active Active
- 2007-03-21 JP JP2009500864A patent/JP5285595B2/ja not_active Expired - Fee Related
- 2007-03-21 PT PT07727166T patent/PT1996229E/pt unknown
- 2007-03-21 SI SI200730184T patent/SI1996229T1/sl unknown
- 2007-03-21 EP EP09178084A patent/EP2158921B1/en active Active
- 2007-03-21 EA EA200870361A patent/EA014532B1/ru not_active IP Right Cessation
- 2007-03-21 DE DE602007003815T patent/DE602007003815D1/de active Active
- 2007-03-21 PT PT09178084T patent/PT2158921E/pt unknown
- 2007-03-21 SA SA07280116A patent/SA07280116B1/ar unknown
- 2007-03-21 CA CA002646895A patent/CA2646895A1/en not_active Abandoned
- 2007-03-21 WO PCT/EP2007/052690 patent/WO2007107585A1/en active Application Filing
- 2007-03-21 PL PL09178084T patent/PL2158921T3/pl unknown
- 2007-03-21 KR KR1020087025693A patent/KR20090016659A/ko not_active Application Discontinuation
- 2007-03-21 PL PL07727166T patent/PL1996229T3/pl unknown
- 2007-03-21 AU AU2007228736A patent/AU2007228736B2/en not_active Ceased
- 2007-03-21 MY MYPI20083534A patent/MY142996A/en unknown
- 2007-03-21 AT AT09178084T patent/ATE539766T1/de active
- 2007-03-21 BR BRPI0709864-2A patent/BRPI0709864A2/pt not_active IP Right Cessation
- 2007-03-21 DK DK07727166.6T patent/DK1996229T3/da active
- 2007-03-21 EP EP07727166A patent/EP1996229B1/en active Active
-
2008
- 2008-09-02 IL IL193840A patent/IL193840A/en not_active IP Right Cessation
- 2008-10-22 NO NO20084452A patent/NO20084452L/no not_active Application Discontinuation
-
2010
- 2010-03-12 HR HR20100144T patent/HRP20100144T1/hr unknown
-
2012
- 2012-01-05 HR HR20120013T patent/HRP20120013T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1115308T1 (el) | Συνθεσεις εμβολιου οι οποιες περιεχουν ανοσοενισχυτικο εκδοχο σαπωνινης | |
MX2010001054A (es) | Composiciones adyuvantes antigenicas y metodos. | |
Geeraedts et al. | Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs | |
AR052625A1 (es) | Nueva composicion | |
BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
Baz et al. | Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice | |
CU23404A1 (es) | Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes | |
NO20005051L (no) | Adjuvantsammensetninger | |
EA200900024A1 (ru) | Противогриппозная вакцина | |
CY1120430T1 (el) | Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων | |
UY31285A1 (es) | Vacunas | |
MXPA04001509A (es) | Particulas de fosfato de calcio como coadyuvantes para la mucosa. | |
WO2014205199A3 (en) | Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency | |
CO6561819A2 (es) | Vectores para vacunas y método para potenciar respuestas inmunes | |
BR112014011345A2 (pt) | partículas tipo vírus da influenza (vlps) compreendendo nicotiana tabacum produzida por hemaglutinina | |
BR112015021523A2 (pt) | composição de uma vacina contra a tosse convulsa acelular, e, métodos para vacinar um sujeito contra a bordetella pertussis e para proteger um sujeito da tosse convulsa | |
AR059972A1 (es) | Administracion intranasal o inhalacional de virosomas | |
BRPI0606614A2 (pt) | peptìdeos para distribuição de vacinas na mucosa | |
Cao et al. | Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice | |
AR093530A1 (es) | Adyuvante de vacunacion, preparacion, y vacunas que lo contienen | |
Altenburg et al. | Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice | |
NZ583377A (en) | Method of eliciting an immune response against pandemic influenza virus | |
BRPI0414073A (pt) | método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo | |
BR112022007474A2 (pt) | Vacina de partículas semelhantes a vírus chikungunya e métodos de uso da mesma | |
AR038311A1 (es) | Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal | ||
FA | Abandonment or withdrawal |